- BioLife Plasma Services, part of Takeda (TAK, Financial), introduces Fresenius Kabi Adaptive Nomogram technology to enhance plasma collection across its U.S. centers.
- The technology promises an average 11.5% increase in plasma collection per donor using the Aurora Xi Plasmapheresis System.
- Full integration of the technology is expected by December 2025 in all centers employing the Aurora Xi system.
BioLife Plasma Services, a division of Takeda (TAK), has announced the rollout of the new Fresenius Kabi Adaptive Nomogram technology throughout its network of plasma donation centers across the United States. This innovative technology, utilized in conjunction with the Aurora Xi Plasmapheresis System, promises to optimize the plasma collection process by tailoring it to the unique characteristics of each donor. Clinical trials have indicated a significant ~11.5% increase in plasma collection per donor on average.
The integration of this adaptive technology is expected to cover all U.S. plasma donation centers deploying the Aurora Xi system by the end of December 2025. This marks a significant step forward in enhancing operational efficiency and ensuring a robust plasma supply, essential for the production of lifesaving and life-sustaining medicines developed by Takeda.
"This rollout is a testament to our investment in cutting-edge technology to elevate operational efficiency while safeguarding donor safety," stated Hema Tallman, SVP and Global Head of BioLife Plasma Services. Dr. Christian Hauer, President, MedTech at Fresenius Kabi, emphasized the role of this advancement in supporting plasma centers and the critical therapies they provide to patients.
BioLife Plasma Services aims for full implementation of new personalized nomograms, including both Fresenius Kabi’s Adaptive Nomogram and Haemonetics Persona Nomogram, in all centers by March 2026. This initiative underscores BioLife's commitment to contributing to the advancement of plasma-derived therapies, ensuring a sustained supply of critical medicines for those in need.
